Atglistatin
-
Catalog numberB1864-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_name3-[3-[4-(dimethylamino)phenyl]phenyl]-1,1-dimethylurea
-
DescriptionAtglistatin is a potent, and selective inhibitor of adipose triglyceride lipase (ATGL) the rate limiting enzyme involved in fatty acid mobilization and prevention of lipolysis. It does not inhibit hormone-sensitive lipase, monoglyceride lipase, pancreatic lipase, lipoprotein lipase, or other lysophospholipases. Atglistatin also prevents triglyceride accumulation after acute myocardial infarction, displaying cardioprotective benefit.
-
CAS Number1469924-27-3
-
Structure AvailableYes
-
Molecular FormulaC₁₇H₂₁N₃O
-
Molecular Weight283.37
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>15 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA potent and selective adipose triglyceride lipase (ATGL) inhibitor
-
Storage Condition-20°C
-
Shipping ConditionGel Pack
-
Shelf Life36 months
-
PubChem CID71699712
-
SMILESCN(C)C1=CC=C(C=C1)C2=CC(=CC=C2)NC(=O)N(C)C
-
InChiInChI=1S/C17H21N3O/c1-19(2)16-10-8-13(9-11-16)14-6-5-7-15(12-14)18-17(21)20(3)4/h5-12H,1-4H3,(H,18,21)
-
InChi KeyAWOPBSAJHCUSAS-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameAtglistatin
-
Alternative nameAtglistatin
-